AIMOVIG sol inj 70 mg/ml stylo pré-remp 1 ml
7680667480020
CH-66748
N02CD01
02.05.1.
Reimbursement limitations:
AIMOVIG4
Le traitement nécessite une garantie de prise en charge des frais par l’assureur maladie, après …
1 / 3
google
Details
- Product number
- 6674801
- CPT
- -
- Packaging group
- 1 x 1 ml
- Unit
- Injektor(en), vorgefüllt/Pen
- Composition
- erenumabum 70 mg, saccharum, polysorbatum 80, acidum aceticum glaciale, natrii hydroxidum corresp. natrium 0.2 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Aimovig 70 mg/ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1 x 1 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
70.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.2 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 437.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2018
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 66748
- Drug name
- Aimovig, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- N02CD01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 13/07/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 02.05.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AIMOVIG sol inj 70 mg/ml stylo pré-remp 1 ml
- Description (DE)
- AIMOVIG Inj Lös 70 mg/ml Fertigpen 1 ml
- Market launch
- 13/07/2018
- Narcotic (BTM)
- No